Diagnosis of recurrent gynecologic malignancy with fine-needle aspiration cytology.
Between 1980-1985, 177 fine-needle aspirations were performed on 139 patients suspected of having recurrent gynecologic malignancy. Suspected sites of recurrence included a pelvic mass (122), peripheral lymph node (39), and a variety of other locations (16). There were 69 positives, 79 negatives, eight suspicious specimens, and 21 specimens inadequate for interpretation. Excluding suspicious or inadequate specimens, the results of the remaining 148 evaluable aspirations were confirmed by histopathologic correlation (35) or subsequent clinical course (113). Because there were no false positives, the specificity of the technique was 100%. The sensitivity was 68%, with an associated false-negative rate of 32%. The predictive value of a positive was 100%; that of a negative was 57%. An analysis of the false-negative results failed to show a correlation with cell type, lesion location, previous radiotherapy, or previous chemotherapy. The complication rate was less than 1%. These data support the conclusion that fine-needle aspiration cytology is a safe, highly specific method for diagnosing recurrent gynecologic malignancy. However, in patients with negative fine-needle aspiration cytology and suspected recurrent disease, it would appear that further evaluation is indicated.
Nash
J D
JD
Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland.
Burke
T W
TW
Woodward
J E
JE
Hall
K L
KL
Weiser
E B
EB
Heller
P B
PB
D001707:Biopsy, Needle / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005188:False Negative Reactions; D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology*; D006406:Hematoma / Q000209:etiology / Q000601:surgery; D006801:Humans; D007239:Infections / Q000601:surgery; D009364:Neoplasm Recurrence, Local; D012187:Retroperitoneal Space / Q000098:blood supply